A wearable robotic device called the Hybrid Assistive Limb (HAL) can improve walking ability in people with amyotrophic…
Marisa Horak, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Horak, MS
Delivering gentle electrical stimulation to the spinal cord can reduce the buildup of toxic TDP-43 protein clumps in a mouse…
A novel treatment for amyotrophic lateral sclerosis (ALS) caused by mutations in a specific gene called CHCHD10 showed promise for…
Common viral infections such as influenza and COVID-19 may accelerate the onset and progression of amyotrophic lateral sclerosis (ALS),…
The amyotrophic lateral sclerosis (ALS) community is mourning Brooke Eby, an ALS advocate who documented her life with the…
Advocates are cheering as legislation that would renew the Accelerating Access to Critical Therapies (ACT) for amyotrophic lateral sclerosis…
Coya Therapeutics is approaching full enrollment in its main clinical trial for COYA 302, an experimental therapy for…
Filmmaker and University of Virginia graduate Chris Farina had the idea for a documentary about death and dying about 10…
Enrollment of adults with mild-to-moderate amyotrophic lateral sclerosis (ALS) has been completed in a clinical trial testing PHENOGENE-1A as…
People with amyotrophic lateral sclerosis (ALS) who are exposed to high levels of certain pollutants in the years before…